v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
REVENUE:      
Total revenue $ 1,618,499 $ 1,526,594 $ 1,321,776
OPERATING COSTS AND EXPENSES:      
Cost of commissions and other services revenue 312,153 305,127 318,798
Cost of goods sold—pharmacy revenue 730,748 630,340 405,004
Marketing and advertising 313,687 319,505 358,858
Selling, general, and administrative 149,022 164,442 141,042
Technical development 38,965 38,681 33,524
Total operating costs and expenses 1,544,575 1,458,095 1,257,226
INCOME FROM OPERATIONS 73,924 68,499 64,550
INTEREST EXPENSE, NET (44,527) (79,385) (93,551)
CHANGE IN FAIR VALUE OF WARRANTS 55,804 59,525 0
LOSS ON EXTINGUISHMENT OF DEBT (8,659) 0 0
OTHER EXPENSE, NET (255) (128) (65)
INCOME (LOSS) BEFORE INCOME TAX EXPENSE 76,287 48,511 (29,066)
INCOME TAX EXPENSE 14,098 931 5,059
NET INCOME (LOSS) 62,189 47,580 (34,125)
Senior Non-Convertible Preferred Stock accumulated dividends and accretion (73,838) (22,548) 0
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (11,649) $ 25,032 $ (34,125)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE:      
Basic (in dollars per share) $ (0.06) $ 0.14 $ (0.20)
Diluted (in dollars per share) $ (0.06) $ 0.01 $ (0.20)
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:      
Basic (in shares) 188,174 176,148 168,519
Diluted (in shares) 188,174 181,895 168,519
OTHER COMPREHENSIVE LOSS, NET OF TAX:      
Unrealized gain (loss), net of related tax benefit for the year ended June 30, 2026, and 2025, of $0.0 million,and $0.1 million, and tax expense for the year ended June 30, 2024 of $0.3 million. $ 0 $ (432) $ 1,214
Net reclassification into earnings 0 (3,680) (10,781)
OTHER COMPREHENSIVE LOSS 0 (4,112) (9,567)
COMPREHENSIVE INCOME (LOSS) 62,189 43,468 (43,692)
Commissions and other services      
REVENUE:      
Total revenue 787,645 797,841 856,923
Pharmacy      
REVENUE:      
Total revenue $ 830,854 $ 728,753 $ 464,853